Rapid SDH

by RapidAI (formerly iSchemaView)  · Based in United States →Where AI meets patient care.
Emergency Medicine Neurosurgery Radiology

Contact vendor
Regulatory Status Disclosed

Overview

Rapid SDH is an AI-powered module developed by RapidAI (formerly iSchemaView) for the detection and notification of suspected hemispheric acute and chronic subdural hematoma (SDH) on non-contrast CT scans. This radiological computer-assisted triage and notification software provides critical information to clinicians in one minute or less, aiding in time-sensitive treatment decisions for trauma patients and those with hemorrhagic stroke. It boasts a high positive predictive value of 99% (93% sensitivity, 99% specificity) for SDHs greater than 1ml. Rapid SDH integrates with the Rapid mobile app, PACS, and email to send automated notifications, streamlining workflow and expediting patient care across hospital systems. It is part of RapidAI’s comprehensive hemorrhagic and trauma care AI solution.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-powered detection of suspected hemispheric acute and chronic subdural hematoma (SDH)
  • Notifications to clinicians in one minute or less
  • High positive predictive value (PPV) of 99% (93% sensitivity, 99% specificity) for SDHs >1ml
  • Integration with Rapid mobile app, PACS, and email for notifications
  • Part of a comprehensive hemorrhagic and trauma care AI solution (with Rapid ICH and Rapid Hyperdensity)
  • Analyzes non-contrast CT scans
  • Aids in streamlining decision-making and expediting patient care
  • Supports identification of treatment eligibility

Use Cases

  • Triage and notification of suspected subdural hematoma
  • Expediting treatment decisions for traumatic brain injury and hemorrhagic stroke patients
  • Workflow management for radiologists and neurocritical care teams
  • Facilitating patient transfer and treatment decisions across hospital systems
  • Improving patient outcomes in neurocritical care

What Physicians Need to Know

Evidence Base
Rapid SDH is an AI-powered module leveraging intelligence from analyzing hundreds of patient scans for the detection of suspected hemispheric acute and chronic subdural hematoma on non-contrast CT scans. It received FDA clearance in November 2023. The tool is part of RapidAI's comprehensive hemorrhagic and trauma care AI solution, which also includes modules for intracranial hemorrhage (ICH) and hyperdensity.
Clinical Validation Studies
A retrospective, multicenter study, comparing Rapid SDH performance against the consensus of three expert neuroradiologists, demonstrated a sensitivity of 92.4% and specificity of 98.7% for SDH detection. For suspected acute and chronic hemispheric subdural hematomas >1mL, it offers an industry-leading positive predictive value (PPV) of 99% (sensitivity 93%, specificity 99%). The median processing time for results is approximately 45-60 seconds.
Clinical Workflow Integration
Rapid SDH automatically processes non-contrast CT images and sends results and notifications to the entire care team across hospital systems or treatment networks within 60 seconds. Notifications are delivered through the Rapid mobile app, PACS, and email, facilitating faster treatment and transfer decisions for patients with traumatic brain injury or hemorrhagic stroke.
Physician Tip

Rapid SDH offers rapid, AI-powered detection of subdural hematomas on CT scans, providing critical information within a minute to aid in time-sensitive treatment decisions. Leverage the automated notifications via mobile app, PACS, and email to ensure prompt communication across the care team. Integrate this tool with other RapidAI modules (e.g., Rapid ICH, Rapid Hyperdensity) for a comprehensive assessment of hemorrhagic and trauma cases. While the tool excels in detection, always correlate findings with the patient's clinical presentation and consider the broader differential diagnoses for neurological symptoms. The high sensitivity and specificity can significantly expedite diagnosis and care coordination.

Rapid SDH is designed for seamless integration into existing clinical workflows, primarily through its compatibility with Picture Archiving and Communication Systems (PACS) and its dedicated mobile application. It also supports email notifications for broad team communication. The platform is part of a larger suite of RapidAI products, allowing for a unified AI-powered solution for various neurovascular and trauma conditions, enhancing a holistic approach to patient assessment and management within hospital systems and treatment networks.

Details

Category Neurology AI, Radiology & Imaging AI, Triage & ER/ICU AI
Pricing Contact vendor
DeploymentCloud-based, On-premise
Compliance
BAA Available Yes AI-estimated
HIPAA Compliant Yes AI-estimated
FDA Status Yes AI-estimated

Rapid SDH is a radiological computer-assisted triage and notification software indicated for use in the triage and notification of hemispheric SDH in non-enhanced head images. The device is intended to assist trained radiologists in workflow triage by providing notification of suspected findings.

Integrations
EHR Not specified
Specialties Emergency Medicine, Neurosurgery, Radiology

What the Web Says

Rapid SDH, part of the RapidAI platform, is an AI-powered solution designed to detect intracranial hemorrhage (ICH) and mass effect from CT scans, aiming to accelerate diagnosis and treatment for stroke and trauma patients. Reviews highlight its speed and accuracy in identifying critical conditions, potentially improving patient outcomes by reducing time to intervention.

Overall: Positive

Strengths

  • Rapid and accurate detection of intracranial hemorrhage and mass effect.
  • Significantly reduces time to diagnosis and treatment for critical conditions.
  • Integrates with existing PACS and hospital systems.
  • Aids in prioritizing critical cases for radiologists and neurologists.
  • Potential to improve patient outcomes in stroke and trauma.
  • User-friendly interface according to some reviews.

Limitations

  • Cost can be a barrier for smaller institutions.
  • Requires integration and IT support for implementation.
  • Reliance on AI may lead to over-reliance or overlooking subtle findings (though not widely reported).
  • Some initial skepticism from physicians regarding AI accuracy (generally overcome with use).
  • Specific training may be needed for optimal use by clinical staff.
  • Limited detailed negative reviews available, suggesting overall positive reception.

Based on reviews from: RapidAI Website, G2, Capterra, Healthcare IT News, Physician forums/discussions (general sentiment), Radiology Today

Last updated: 2026-07-18

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Rapid SDH

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

RapidAI
RapidAI Receives FDA Clearance of AI Module for Detection of Hemispheric Subdural Hematomas
RapidAI announced FDA clearance for Rapid SDH, an AI-powered module designed for the detection and notification of suspected hemispheric acute and chronic subdural hematoma, aiming to enhance comprehensive trauma care.
2023-11
Healio
Imaging analysis software accurately detects subdural hematoma - Healio
A novel imaging analysis technique, Rapid SDH, demonstrated high sensitivity (92.4%) and specificity (98.7%) in identifying both the presence and type of subdural hematoma, with a median processing time of 45 seconds.
2025-02
RapidAI
RapidAI Reveals Superiority Over Competition in LVO Detection u2013 33% More Cases Identified Than Leading Competitor
RapidAI presented new data at the International Stroke Conference, including landmark research on subdural hematoma (SDH) detection, reinforcing its AI-powered stroke care capabilities.
2025-02
Market Research Future
Stroke Post Processing Software Market Size, Report 2035 - Market Research Future
A market report highlights RapidAI's FDA clearance for Rapid SDH in Q2 2024, expanding its stroke imaging portfolio with software that automates the detection and quantification of subdural hematomas.
2026-04
Diagnostic Imaging
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD | Diagnostic Imaging
A study presented at the International Stroke Conference found that Rapid SDH software achieved 92.4% sensitivity and 98.7% specificity for subdural hematoma detection on non-contrast-enhanced head CTs.
2025-02
American Heart Association Journals (Stroke)
Abstract WMP63: Performance of RAPID SDH for detection of both Acute and Chronic Subdural Hematomas | Stroke - American Heart Association Journals
This peer-reviewed abstract details a multicenter study confirming that Rapid SDH provides fast and accurate detection of both acute and chronic SDH on non-enhanced head CT, with a median processing time of approximately 45 seconds.
2025-01
RapidAI
RapidAI Announces a Series of Industry Firsts u2013 Unique Rapid Edge Cloud Platform, Breakthrough AI Non-Contrast CT Suite, International Expansion in Japan
RapidAI announced its breakthrough AI offering, including Rapid SDH, as part of a unique suite of non-contrast CT solutions for stroke, designed to identify suspected stroke cases upon the first CT scan.
2023-12
FDA
K232436 - 510(k) Premarket Notification - FDA
This regulatory document details the 510(k) premarket notification for Rapid SDH, a radiological computer-aided triage and notification software indicated for hemispheric subdural hematoma detection in non-enhanced head CT images.
2026-05

Videos

Product demos, reviews, and walkthroughs for Rapid SDH.

Loading videos...

View all on YouTube

No FAQs available yet for this tool.

Related Tools

DETECT-ME/CFS project
ME/CFS Research Foundation (Sponsor: Federal Ministry of Health (BMG))
Clinical Decision Support & Reference
The DETECT-ME/CFS project is developing an AI-supported clinical decision support system to improve the rapid and reliable diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Neurotrack
Neurotrack
Clinical Decision Support & Reference
Neurotrack is a cognitive care enablement platform that provides clinically validated, FDA class II device assessments and care planning support to identify and manage cognitive decline and dementia earlier and with greater accuracy.
LesionQuant
CorTechs Labs
Neurology AI
LesionQuant, an FDA-approved AI product by CorTechs Labs, is particularly useful for patients with multiple sclerosis. It provides brain structure data and quantifies the number, size, and location of lesions, comparing them to prior studies.
ExcelsiusGPS
Globus Medical
Neurology AI
ExcelsiusGPS™ is the first and only robotic navigation platform on the market that offers a comprehensive approach to spine and cranial procedures, from start to finish. The system enables repeatable and accurate trajectory alignment and navigation for placing screws, interbody implants, and cranial instruments.
Onera SleepMap
Onera B.V.
Neurology AI
Onera SleepMap is an AI-powered sleep analysis software that processes polysomnography data, part of Onera Health's innovative patch-based system for at-home and in-lab sleep studies. The system aims to make clinical-grade sleep diagnostics more accessible and user-friendly, providing comprehensive data comparable to traditional in-lab PSG.
JLK-NCCT
JLK-NCCT
Clinical Decision Support & Reference
JLK-NCCT is an AI software designed to assist in the analysis of non-contrast CT brain scans for the detection of acute ischemic stroke.

See all Neurology AI tools →

More from RapidAI (formerly iSchemaView)

iSchemaView RAPID
RapidAI (formerly iSchemaView)
Neurology AI
RapidAI is an AI-enabled software platform that facilitates the viewing, processing, and analysis of CT and MRI imaging to aid clinicians in assessing patients with suspected stroke, providing automated results for faster, more accurate diagnostic and treatment decisions.
Rapid
RapidAI (formerly iSchemaView)
Neurology AI
RapidAI is an AI-driven medical imaging analysis and coordinated care platform that empowers healthcare teams to rapidly, precisely, and confidently manage life-threatening conditions, especially acute stroke, through advanced CT and MRI image processing.
Rapid CTA 360
RapidAI (formerly iSchemaView)
Neurology AI
Rapid CTA 360 by RapidAI (formerly iSchemaView) is an AI-powered imaging solution providing automated 3D CTA reconstructions for rapid and precise stroke diagnosis and treatment planning, enhancing visibility of occlusions and collateral flow.
Rapid LVO
RapidAI (formerly iSchemaView)
Neurology AI
Rapid LVO by RapidAI is an FDA-cleared AI tool for the fast and accurate detection of Large Vessel Occlusions (LVOs) in acute stroke patients using CTA imaging, streamlining triage and care coordination.

View company profile →

Suggest an Edit → | Last Verified: 2026-04-18 | First Added: 2026-04-18
AI Tool Finder
AI-powered search. Results may not be comprehensive.